{'output': [['Alder Biopharmaceuticals Inc', 'ORG', 'Announce', 'Eptinezumab', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Relate_To', 'Promise 2 Phase 3 Clinical Trial', 'EVENT'], ['Eptinezumab', 'CONCEPT', 'Significantly Reduces', 'Migraine Risk', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Meets', 'Primary Endpoint', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Meets', 'All Key Secondary Endpoints', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Operate_In', 'Chronic Migraine Prevention', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Has', '15% Of Patients', 'ECON_INDICATOR'], ['15% Of Patients', 'ECON_INDICATOR', 'Has', 'No Migraines', 'CONCEPT'], ['No Migraines', 'CONCEPT', 'For', 'A Full Three Months', 'TIME'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Has', 'Very High Statistical Significance', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Has', 'Safety And Tolerability', 'CONCEPT'], ['Safety And Tolerability', 'CONCEPT', 'Similar To', 'Previously Reported Eptinezumab Studies', 'CONCEPT'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Plans To Submit', 'Bla', 'CONCEPT'], ['Bla', 'CONCEPT', 'To', 'U.S. FDA', 'ORG/GOV'], ['Alder Biopharmaceuticals Inc', 'ORG', 'Plans To Submit', 'Bla', 'CONCEPT'], ['Bla', 'CONCEPT', 'In', 'H2 Of 2018', 'TIME']]}